LIVESTREAM: http://videoexchange.mayo.edu/webcasts

Viewers who have access to Sharepoint can view live without VPN https://mctools.sharepoint.com/teams/PEPS/VideoStreaming/

Headache
Mark Whealy, M.D.
"New Daily Persistent Headache"

Learning Objectives
Upon conclusion of this activity, participants will be able to:

• Describe the  ICHD-3 diagnostic criteria for new daily persistent headache
• Recognize the vast differential diagnosis for someone presenting with a new daily persistent headache
• Review the current treatment approach to new daily persistent headache

Dr. Whealy (nor spouse/partner) do not have any relevant financial relationship to disclose and does intend to discuss off-label/investigative uses(s) of the following commercial product(s)/device(s): Cefaly: Topiramate; OnabotulinumtoxinA; Gabapentin; Methylprednisolone; Ketamine; Lidocaine; Mexilitine; Doxycycline; Amitriptyline.

TRANSCRIPTATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.